The Human papillomavirus (HPV)
family includes virus "types" that are responsible
for a diverse number of human skin ailments including common
plantar warts and cervical cancer. HPV Type 16 (HPV-16) , one
of approximately 70 different HPVs types, is usually acquired
during adulthood and is responsible for many cancerous and precancerous
genital condition in women.
Controlling HPV infections is an important public health goal.
In 1997 alone, more than 180,000 first-time visits to physicians
by adults in the U.S. were due to an HPV-related genital condition.
As many as 24,000,000 American men and women have been infected
with genital HPV types and between 500,000 and 1,000,000 new
infections develop each year. Some experts estimate that as
many as 40% to more than 70% of adult Americas may be infected
with this virus during their lifetime.
There are no known treatments to
cure HPV infection; the only treatments we have available are
those that treat the outward symptoms of infections, e.g., warts.
For most people, their immune system seems to control or possibly
eliminate the infection within one to two years of its beginning.
It is unclear whether previously infected men and women become
more likely to show active HPV infection as they age. We know
the immune system becomes less efficient as we age and that
this factor might contribute to development of HPV infection
among older people.
Irrespective of age, on occasion,
the immune system is unable to eliminate or control HPV infection
and "persistent HPV infection" develops. It is possible
that persistent (HPV) infection may influence whether precancerous
and cancerous changes develop in infected cells.